Charter Bioanalytics is an independent third-party laboratory for peptide identity, purity, mass, and endotoxin testing. Every report is method-validated per ICH Q2(R1), USP <85>, and ISO/IEC 17025 principles — designed for traceability, not just a number on a page.
Every Charter report carries the same structural integrity — identity, purity, mass accuracy, and endotoxin — graded against published thresholds, with per-criterion verdicts and a clear audit trail.
RP-HPLC with diode-array detection, n=3. Retention-time match against reference standard. Purity reported to three decimals. Threshold: ≥ 99.0% PASS · 95.0–98.99% CAUTION · <95.0% FAIL.
Gravimetric per-vial assay, n=3, calibrated balance. Result reported as measured / labelled (% delta). Tolerance: ±10% PASS, >+10% OVERFILL (not a safety flag), <−10% UNDERFILL (dosing risk).
Kinetic chromogenic LAL via Lonza Endosafe nexgen-PTS. Method per USP <85> / EP 2.6.14. Threshold: < 0.5 EU/mg for parenteral-grade research material.
Other labs return a number. Charter returns a verdict — graded against published thresholds, with per-criterion chips, traceable methods, and an authentication ID on every report.
When a customer asks “is this real?”, we want the answer to be one click and one read.
Identity Tier reports return in 3 business days. Comprehensive panel in 5. Send your sample with the chain-of-custody form — we handle the rest.
Start a submission